An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Saved in:
| Title: | An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. |
|---|---|
| Authors: | Lin YH; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Satani N; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston, Houston, TX, USA., Hammoudi N; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yan VC; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barekatain Y; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khadka S; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ackroyd JJ; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Georgiou DK; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pham CD; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arthur K; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maxwell D; Institutional Analytics & Informatics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Peng Z; Cardtronics, Inc, Houston, TX, USA., Leonard PG; Core for Biomolecular Structure and Function, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Czako B; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pisaneschi F; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mandal P; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun Y; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zielinski R; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pando SC; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang X; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tran T; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu Q; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu Q; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang Y; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kang Z; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Asara JM; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Priebe W; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bornmann W; Director of Drug Discovery and Development, Advanced Organic Synthesis LLC, Houston, Texas, USA., Marszalek JR; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., DePinho RA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Muller FL; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA. aettius@aol.com. |
| Source: | Nature metabolism [Nat Metab] 2020 Dec; Vol. 2 (12), pp. 1413-1426. Date of Electronic Publication: 2020 Nov 23. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33230295 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+YH%22">Lin YH</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Satani+N%22">Satani N</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hammoudi+N%22">Hammoudi N</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yan+VC%22">Yan VC</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Barekatain+Y%22">Barekatain Y</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Khadka+S%22">Khadka S</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ackroyd+JJ%22">Ackroyd JJ</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Georgiou+DK%22">Georgiou DK</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pham+CD%22">Pham CD</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Arthur+K%22">Arthur K</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Maxwell+D%22">Maxwell D</searchLink>; Institutional Analytics & Informatics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peng+Z%22">Peng Z</searchLink>; Cardtronics, Inc, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Leonard+PG%22">Leonard PG</searchLink>; Core for Biomolecular Structure and Function, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Czako+B%22">Czako B</searchLink>; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pisaneschi+F%22">Pisaneschi F</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mandal+P%22">Mandal P</searchLink>; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zielinski+R%22">Zielinski R</searchLink>; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pando+SC%22">Pando SC</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tran+T%22">Tran T</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Xu+Q%22">Xu Q</searchLink>; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Pharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kang+Z%22">Kang Z</searchLink>; Institute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Asara+JM%22">Asara JM</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Priebe+W%22">Priebe W</searchLink>; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bornmann+W%22">Bornmann W</searchLink>; Director of Drug Discovery and Development, Advanced Organic Synthesis LLC, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Marszalek+JR%22">Marszalek JR</searchLink>; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DePinho+RA%22">DePinho RA</searchLink>; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Muller+FL%22">Muller FL</searchLink>; Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA. aettius@aol.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101736592%22">Nature metabolism</searchLink> [Nat Metab] 2020 Dec; Vol. 2 (12), pp. 1413-1426. <i>Date of Electronic Publication: </i>2020 Nov 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101736592 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2522-5812 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225225812%22">25225812 </searchLink><i>NLM ISO Abbreviation: </i>Nat Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33230295 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42255-020-00313-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1413 Titles: – TitleFull: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin YH – PersonEntity: Name: NameFull: Satani N – PersonEntity: Name: NameFull: Hammoudi N – PersonEntity: Name: NameFull: Yan VC – PersonEntity: Name: NameFull: Barekatain Y – PersonEntity: Name: NameFull: Khadka S – PersonEntity: Name: NameFull: Ackroyd JJ – PersonEntity: Name: NameFull: Georgiou DK – PersonEntity: Name: NameFull: Pham CD – PersonEntity: Name: NameFull: Arthur K – PersonEntity: Name: NameFull: Maxwell D – PersonEntity: Name: NameFull: Peng Z – PersonEntity: Name: NameFull: Leonard PG – PersonEntity: Name: NameFull: Czako B – PersonEntity: Name: NameFull: Pisaneschi F – PersonEntity: Name: NameFull: Mandal P – PersonEntity: Name: NameFull: Sun Y – PersonEntity: Name: NameFull: Zielinski R – PersonEntity: Name: NameFull: Pando SC – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Tran T – PersonEntity: Name: NameFull: Xu Q – PersonEntity: Name: NameFull: Wu Q – PersonEntity: Name: NameFull: Jiang Y – PersonEntity: Name: NameFull: Kang Z – PersonEntity: Name: NameFull: Asara JM – PersonEntity: Name: NameFull: Priebe W – PersonEntity: Name: NameFull: Bornmann W – PersonEntity: Name: NameFull: Marszalek JR – PersonEntity: Name: NameFull: DePinho RA – PersonEntity: Name: NameFull: Muller FL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2522-5812 Numbering: – Type: volume Value: 2 – Type: issue Value: 12 Titles: – TitleFull: Nature metabolism Type: main |
| ResultId | 1 |